1. Home
  2. PBF vs EWTX Comparison

PBF vs EWTX Comparison

Compare PBF & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PBF Energy Inc.

PBF

PBF Energy Inc.

N/A

Current Price

$50.02

Market Cap

4.0B

Sector

Energy

ML Signal

N/A

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

N/A

Current Price

$30.52

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBF
EWTX
Founded
2008
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.3B
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
PBF
EWTX
Price
$50.02
$30.52
Analyst Decision
Hold
Buy
Analyst Count
10
8
Target Price
$33.30
$37.38
AVG Volume (30 Days)
3.8M
730.2K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.23%
N/A
EPS Growth
69.78
N/A
EPS
N/A
N/A
Revenue
$24,508,200,000.00
N/A
Revenue This Year
$1.73
N/A
Revenue Next Year
$0.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$10.60
52 Week High
$50.47
$31.82

Technical Indicators

Market Signals
Indicator
PBF
EWTX
Relative Strength Index (RSI) 69.28 55.34
Support Level $27.35 $26.91
Resistance Level N/A $31.28
Average True Range (ATR) 2.83 1.48
MACD 0.52 -0.01
Stochastic Oscillator 95.84 73.82

Price Performance

Historical Comparison
PBF
EWTX

About PBF PBF Energy Inc.

PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines, and storage facilities. The Logistics segment consists solely of PBFX's operations.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: